Saro Armenian, D.O., MPH, is the Barron Hilton Chair in Pediatrics and the Director of the Division of Outcomes Research/Intervention in the Department of Population Sciences at City of Hope® Cancer Center Duarte. He directs the Center for Survivorship and Outcomes in the Hematologic Malignancies Research Institute and the Childhood, Adolescent and Young Adult Survivorship Program.
Dr. Armenian is an internationally recognized physician-scientist focused on improving the health outcomes of childhood and adult-onset cancer patients. He is a Leukemia & Lymphoma Society Research Scholar and has been the recipient of several National Institutes of Health and other prestigious peer-reviewed foundation grants. Dr. Armenian has also published extensively in high-impact journals, including Lancet Oncology, Journal of Clinical Oncology, Blood, and JAMA Oncology. His clinical expertise lies in hematologic cancers, and he is an invited member of the National Comprehensive Cancer Network Expert Panel for Pediatric Aggressive Mature B-Cell Lymphoma and Pediatric Hodgkin Lymphoma. Dr. Armenian is the immediate past chair of the Children’s Oncology Group Survivorship and Outcomes Committee and has led international efforts to establish research priorities as part of the American Society of Clinical Oncology, International Guidelines Harmonization Group for Cancer Survivors, and NIH HCT Consensus Late Effects Initiative. He is the recipient of the Frank H. Oski Lectureship Award from the American Society of Pediatric Hematology Oncology to honor outstanding investigations in pediatric hematology/oncology.
Dr. Armenian completed his undergraduate degree at the University of Chicago, his medical degree at the Western University of Health Sciences, and his training in general pediatrics and pediatric hematology/oncology at Children’s Hospital Los Angeles. In addition, he earned his M.P.H. from the University of Southern California.
